GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » International Biotechnology Trust PLC (LSE:IBT) » Definitions » Total Liabilities

International Biotechnology Trust (LSE:IBT) Total Liabilities : £34.26 Mil (As of Feb. 2024)


View and export this data going back to 1994. Start your Free Trial

What is International Biotechnology Trust Total Liabilities?

International Biotechnology Trust's Total Liabilities for the quarter that ended in Feb. 2024 was £34.26 Mil.

International Biotechnology Trust's quarterly Total Liabilities declined from Feb. 2023 (£35.70 Mil) to Aug. 2023 (£34.55 Mil) and declined from Aug. 2023 (£34.55 Mil) to Feb. 2024 (£34.26 Mil).

International Biotechnology Trust's annual Total Liabilities increased from Aug. 2021 (£24.06 Mil) to Aug. 2022 (£42.03 Mil) but then declined from Aug. 2022 (£42.03 Mil) to Aug. 2023 (£34.55 Mil).


International Biotechnology Trust Total Liabilities Historical Data

The historical data trend for International Biotechnology Trust's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

International Biotechnology Trust Total Liabilities Chart

International Biotechnology Trust Annual Data
Trend Aug14 Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Aug23
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.28 18.81 24.06 42.03 34.55

International Biotechnology Trust Semi-Annual Data
Aug14 Feb15 Aug15 Feb16 Aug16 Feb17 Aug17 Feb18 Aug18 Feb19 Aug19 Feb20 Aug20 Feb21 Aug21 Feb22 Aug22 Feb23 Aug23 Feb24
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 45.54 42.03 35.70 34.55 34.26

International Biotechnology Trust Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

International Biotechnology Trust's Total Liabilities for the fiscal year that ended in Aug. 2023 is calculated as

Total Liabilities=Total Assets (A: Aug. 2023 )-Total Equity (A: Aug. 2023 )
=304.871-270.317
=34.55

International Biotechnology Trust's Total Liabilities for the quarter that ended in Feb. 2024 is calculated as

Total Liabilities=Total Assets (Q: Feb. 2024 )-Total Equity (Q: Feb. 2024 )
=320.769-286.509
=34.26

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


International Biotechnology Trust Total Liabilities Related Terms

Thank you for viewing the detailed overview of International Biotechnology Trust's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


International Biotechnology Trust (LSE:IBT) Business Description

Traded in Other Exchanges
Address
65 Gresham Street, 6th Floor, London, GBR, EC2V 7NQ
International Biotechnology Trust PLC is an investment trust company. It aims at achieving long-term capital growth by investing in biotechnology and other life sciences companies. It seeks to achieve its objective by investing in a diversified portfolio of companies which has good growth prospects. It focuses on investments in biotechnology companies which are engaged in on drug discovery and development, medical devices companies and healthcare services provider. The invests in various financial instruments such as equities, index-linked securities, debt securities, cash deposits, money market instruments and foreign currency exchange transactions. Its revenue comprises of dividend, interest and other income from investment made.

International Biotechnology Trust (LSE:IBT) Headlines

No Headlines